The functions of the avian receptor activator of NF-κB ligand (RANKL) and its receptors, RANK and osteoprotegerin, are evolutionarily conserved

被引:20
|
作者
Sutton, Kate M. C. [1 ,2 ]
Hu, Tuanjun [1 ,2 ]
Wu, Zhiguang [1 ,2 ]
Siklodi, Botond [3 ]
Vervelde, Lonneke [1 ,2 ]
Kaiser, Pete [1 ,2 ]
机构
[1] Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland
[2] Univ Edinburgh, R D SVS, Easter Bush EH25 9RG, Midlothian, Scotland
[3] CEVA Phylaxia Vet Biol Co Ltd, H-1107 Budapest, Hungary
来源
基金
英国生物技术与生命科学研究理事会;
关键词
Chicken; TNF superfamily; Cytokines; Pro-inflammatory; DC; Macrophages; TUMOR-NECROSIS-FACTOR; ALPHA-DEFICIENT MICE; TNF FAMILY-MEMBER; DENDRITIC CELLS; T-CELLS; CRYSTAL-STRUCTURE; EPITHELIAL-CELLS; IMMUNE-RESPONSE; TERMINAL KINASE; EXPRESSION;
D O I
10.1016/j.dci.2015.03.006
中图分类号
S9 [水产、渔业];
学科分类号
0908 ;
摘要
A new member of the chicken TNF superfamily has recently been identified, namely receptor activator of NF-kappa B ligand (RANKL), as have its signalling receptor, RANK, and its decoy receptor, osteoprotegerin (OPG). In mammals, RANKL and RANK are transmembrane proteins expressed on the surface of Th1 cells and dendritic cells (DC) respectively, whereas OPG is expressed as a soluble protein from osteoblasts and DC. Recombinant soluble chicken RANKL (chRANKL) forms homotrimers whereas chicken OPG (chOPG) forms homodimers, characteristic of these molecules in mammals. ChRANKL, chRANK and chOPG are expressed at the mRNA level in most tissues and organs. ChRANKL is transcriptionally regulated by Ca2+ mobilisation and enhances the mRNA expression levels of pro-inflammatory cytokines in bone marrow-derived DC (BMDC); this is inhibited by both chOPG-Fc and soluble chRANK-Fc. However, chRANKL does not enhance the expression of cell surface markers in either BMDC or BM-derived macrophages (BMM). Furthermore, chRANKL enhances the survival of APC similar to its mammalian orthologue. (C) 2015 The Authors. Published by Elsevier Ltd.
引用
收藏
页码:170 / 184
页数:15
相关论文
共 50 条
  • [1] Molecular characterisation of avian receptor activator of NF-κB ligand and its receptor, RANK
    Sutton, K. M.
    Wu, Z.
    Kaiser, P.
    [J]. IMMUNOLOGY, 2012, 136 : 8 - 9
  • [2] Glucocorticoid regulation of receptor activator of NF-κB (RANK), osteoprotegerin (OPG) and RANK ligand (RANKL) in mouse calvarial bone.
    Swanson, C
    Lorentzon, M
    Conaway, H
    Lerner, UH
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S200 - S200
  • [3] Increased expression of receptor activator of NF-κB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients
    Franchimont, N
    Reenaers, C
    Lambert, C
    Belaiche, J
    Bours, V
    Malaise, M
    Delvenne, P
    Louis, E
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 138 (03): : 491 - 498
  • [4] Functional dissection of osteoprotegerin and its interaction with receptor activator of NF-κB ligand
    Schneeweis, LA
    Willard, D
    Milla, ME
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (50) : 41155 - 41164
  • [5] OSTEOPROTEGERIN AND RECEPTOR ACTIVATOR OF THE NF-κB LIGAND (RANKL) IN EGYPTIAN PATIENTS WITH THALASSEMIA-INDUCED OSTEOPOROSIS
    El Hamid, A. E. D. S. Abd
    Attia, M.
    Saad, A.
    El Nesr, M.
    Saleh, M. Hassan
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 242 - 242
  • [6] Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-κB/receptor activator of NF-κBligand/osteoprotegerin (RANK/RANKL/OPG) pathway
    He, Xiao-Feng
    Zhang, Long
    Zhang, Chun-Hua
    Zhao, Con-Ran
    Li, Heng
    Zhang, Ling-Fei
    Tian, Guo-Feng
    Guo, Ming-Feng
    Dai, Zheng
    Sui, Fu-Ge
    [J]. BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2017, 17 (04) : 295 - 301
  • [7] Receptor Activator of Nuclear Transcription Factor NF-κB (RANK), Its Ligand RANKL, and Natural Inhibitor of RANKL Osteoprotegerin (OPG) in the Blood Serum of Patients with Primary Bone Tumors
    N. E. Kushlinskii
    E. S. Gershtein
    Yu. N. Solov’ev
    Yu. S. Timofeev
    I. V. Babkina
    A. O. Dolinkin
    A. A. Zuev
    O. I. Kostyleva
    [J]. Bulletin of Experimental Biology and Medicine, 2017, 163 : 478 - 481
  • [8] Receptor Activator of Nuclear Transcription Factor NF-κB (RANK), Its Ligand RANKL, and Natural Inhibitor of RANKL Osteoprotegerin (OPG) in the Blood Serum of Patients with Primary Bone Tumors
    Kushlinskii, N. E.
    Gershtein, E. S.
    Solov'ev, Yu. N.
    Timofeev, Yu. S.
    Babkina, I. V.
    Dolinkin, A. O.
    Zuev, A. A.
    Kostyleva, O. I.
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2017, 163 (04) : 478 - 481
  • [9] Receptor activator NF κB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis
    Crotti, T
    Smith, MD
    Hirsch, R
    Soukoulis, S
    Weedon, H
    Capone, M
    Ahern, MJ
    Haynes, D
    [J]. JOURNAL OF PERIODONTAL RESEARCH, 2003, 38 (04) : 380 - 387
  • [10] Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
    Widschwendter, Martin
    Burnell, Matthew
    Fraser, Lindsay
    Rosenthal, Adam N.
    Philpott, Sue
    Reisel, Daniel
    Dubeau, Louis
    Cline, Mark
    Pan, Yang
    Yi, Ping-Cheng
    Evans, D. Gareth
    Jacobs, Ian J.
    Menon, Usha
    Wood, Charles E.
    Dougall, William C.
    [J]. EBIOMEDICINE, 2015, 2 (10): : 1331 - 1339